Transcriptomics

Dataset Information

0

Hydrogen gas inhibits the formation of neutrophil extracellular traps


ABSTRACT: Neutrophil extracellular traps (NETs) contribute to inflammatory pathogenesis, especially in infectious and cardiovascular diseases. H2 gas acts as an antioxidant and has been clinically and experimentally proven to ameliorate inflammation. Therefore, we investigated whether H2 gas could inhibit NET formation associated with excessive neutrophil activation. Phorbol-12-myristate-13-acetate (PMA)-stimulated human neutrophils exposed to H2 exhibited reduced citrullination of histones, membrane disruption by chromatin complexes, and release of NET components over controls. Mechanistically, H2 suppressed the phosphorylation of Ser-139 residue in H2AX, a marker of DNA damage, thereby reducing the expression of CXC-chemokine receptor 4 (CXCR4) in PMA-stimulated neutrophils. Along with the upregulation of CXCR4, the intracellular content of myeloperoxidase (MPO) and the production of MPO-derived hypochlorous acid (HOCl) was increased; however, these effects were markedly suppressed in H2-exposed cultures. Thus, H2 neutralized HOCl produced by the oxidative burst, inhibited DNA damage, and subsequently inhibited NET formation. We further confirmed that inhalation of H2 inhibited the formation and release of NET components in the blood and bronchoalveolar lavage of a lipopolysaccharide-induced sepsis model in mice and aged minipigs. Therefore, H2 therapy has the potential to be a new therapeutic agent for inflammatory diseases involving NETs associated with excessive neutrophil activation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE178883 | GEO | 2022/02/23

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2019-07-15 | PXD012951 | Pride
2024-03-17 | GSE254410 | GEO
2022-09-01 | GSE189875 | GEO
2023-10-07 | GSE215067 | GEO
2024-05-06 | GSE253440 | GEO
2023-07-31 | GSE160143 | GEO
2021-02-18 | PXD015579 | Pride
2008-06-03 | GSE11630 | GEO
2022-10-25 | PXD016143 | Pride
2017-03-31 | MSV000080847 | MassIVE